A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme
Condition(s):Anaplastic Oligoastrocytoma; GlioblastomaLast Updated:October 31, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Anaplastic Oligoastrocytoma; GlioblastomaLast Updated:October 31, 2022Recruiting
Condition(s):Ewing SarcomaLast Updated:November 1, 2022Recruiting
Condition(s):Glioblastoma Multiforme (GBM); Glioblastoma; Glioma of Brain; Glioblastoma, Adult; Brain Tumor; Brain Tumor, Primary; Brain Tumor Adult; Cancer; Brain CancerLast Updated:November 8, 2023Recruiting
Condition(s):MelanomaLast Updated:June 7, 2023Recruiting
Condition(s):Small Cell Lung CancerLast Updated:February 7, 2022Unknown status
Condition(s):Glioma; GlioblastomaLast Updated:August 18, 2023Active, not recruiting
Condition(s):Small Cell Lung Cancer; Metastatic CarcinomaLast Updated:March 28, 2019Unknown status
Condition(s):Glioblastoma MultiformeLast Updated:March 15, 2023Recruiting
Condition(s):Pediatric CancerLast Updated:March 1, 2023Active, not recruiting
Condition(s):Recurrent Central Nervous System NeoplasmLast Updated:January 31, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.